Find out the latest news and activities of the Global Medicines Program at the University of Washington.
UW Global Medicines Program
Understanding the safety of antimalarial medicines used during early pregnancy
With partners in Burkina Faso, Kenya and Mozambique, the Global Medicines Program is coordinating a prospective cohort study in these sub-Saharan African countries addressing the urgent need for improved methods for pharmacovigilanceand better information on the safety of artemisinin combination therapies (ACT) when used during early pregnancy.  ACTs are the most commonly used antimalarials in the world and women in malaria-endemic countries can be exposed inadvertently to ACTs at an early stage of their pregnancy. This project, called the ASAP study, is funded through the Liverpool School of Tropical Medicine-based Malaria in Pregnancy Consortium with support from the Bill and Melinda Gates Foundation. Read More

Expanding access to pharmaceuticals and services in developing countries with new award from USAID
The Global Medicines Program is a core partner to a newly awarded cooperative agreement to Management Sciences for Health (MSH) by the US Agency for International Development (USAID).  This a five-year Cooperative Agreement for the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program follows the current Strengthening Pharmaceutical Systems (SPS) Program.  Under SPS, UW has provided technical assistance and trainings on pharmacovigilance, pharmacoeconomics and pharmaceutical care strategies in the countries of Ethiopia, Namibia, Rwanda, India and Vietnam.  SIAPS will adopt a systems-strengthening approach to ensure the availability of quality pharmaceutical products and effective pharmaceutical services to achieve desired health outcomes in developing countries. Read More
Recent Publications 
Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa. Corbell C, Katjitea I, Mengistu A, Kalemeera F, Sagwa E, Mabirizi D, Lates J, Nwokike J, Fuller S, Stergachis A. Pharmacoepidemiology and Drug Safety. 18 October 2011.
Strengthening Pharmaceutical Care Education in Ethiopia Through Instructional Collaboration. Odegard PS, Tadeg H, Downing D, Suleman S, Bedada W, Paulos G, Mekonnen H,  Negussu M, Bartlein R, Stergachis A.  American Journal of Pharmaceutical Education. 2011: Volume 75, Issue 7, Article 134. 
More Publications
Welcome to Our Newsletter!
Welcome to our Newsletter! 

From Our Director
The Global Medicines Program is one of the newest programs of the University of Washington’s Department of Global Health.   My colleague and co-Director Professor Lou Garrison and I look forward to keeping you informed of our Program news and progress towards improving the use, safety, quality, benefit-risk profile, cost-effectiveness, and affordability of medicines. 

Andy Stergachis, PhD, Professor and Director, Global Medicines Program

Congratulations to Joseph Babigumira
Congratulations to our newest faculty member, Assistant Professor Joseph Babigumira, MBChB, MS, PhD, on his award from the William and Flora Hewlett Foundation through the Institute of International Education (IIE) to support his research in Uganda. More
Copyright © 2012 Global Medicines Program, All rights reserved.
Email Marketing Powered by Mailchimp